ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

Infectious Diseases Society of America

Enders, J. F. (1969) · The Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,296

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191

Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

Cornely, O. A., Maertens, J. A., Winston, D. J., Perfect, J. R., Ullmann, A. J., Walsh, T. J., HELFGOTT, D. C., Hołowiecki, J., Stockelberg, D., Goh, Y. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,802

Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

Kontoyiannis, D. P., Marr, K. A., Park, B. J., Alexander, B. D., Anaissie, E. J., Walsh, T. J., Ito, J., Andes, D. R., Baddley, J. W., Brown, J. M., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651263 · Cited by 1,456

Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis

Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380

Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease

Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P. H., Langston, A. A., Tarantolo, S., Greinix, H., de Azevedo, W. M., Reddy, V. S., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,339

Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia

Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205

A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow Transplantation

Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B. C., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P. J., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,164

A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia

Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039

Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever

Walsh, T. J., Pappas, P., Winston, D. J., Lazarus, H. M., Petersen, F., Raffalli, J., Yanovich, S., Stiff, P., Greenberg, R., Donowitz, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejm200201243460403 · Cited by 979

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200

Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision

Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556

ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014

Høiby, N., Bjarnsholt, T., Moser, C. E., Bassi, G. L., Coenye, T., Donelli, G., Hall‐Stoodley, L., Holá, V., Imbert, C., Kirketerp‐Møller, K., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.10.024 · Cited by 801

Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology

Ashbee, H. R., Barnes, R. A., Johnson, E. M., Richardson, M. D., Gorton, R., & Hope, W. W. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt508 · Cited by 721

Changes in the epidemiological landscape of invasive candidiasis

Lamoth, F., Lockhart, S. R., Berkow, E. L., & Calandra, T. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx444 · Cited by 547

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections

Arendrup, M. C., Boekhout, T., Akova, M., Meis, J. F. G. M., Cornely, O. A., & Lortholary, O. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12360 · Cited by 533

Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM

Cornely, O. A., Sprute, R., Bassetti, M., Chen, W., Groll, A. H., Kurzai, O., Lass‐Flörl, C., Ostrosky-Zeichner, L. L., Rautemaa‐Richardson, R., Revathi, G., et al. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00749-7 · Cited by 458

Mechanisms of Candida Biofilm Drug Resistance

Taff, H. T., Mitchell, K. F., Edward, J. A., & Andes, D. R. (2013) · Future Microbiology · doi:10.2217/fmb.13.101 · Cited by 422

Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines

Styczyński, J., van der Velden, W. J. F. M., Fox, C. P., Engelhard, D., de la Cámara, R., Cordonnier, C., Ljungman, P. T., & on behalf of the Sixth European Conference on Infections in Leukemia, A. J. V. O. T. I. D. W. P. O. T. E. S. O. B. A. M. T. (.-I. (2016) · Haematologica · doi:10.3324/haematol.2016.144428 · Cited by 411

Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients

Bellmann, R., & Smuszkiewicz, P. (2017) · Infection · doi:10.1007/s15010-017-1042-z · Cited by 418

Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008

Pfaller, M. A., Andes, D. R., Diekema, D. J., Horn, D. L., Reboli, A. C., Rotstein, C., Franks, B., & Azie, N. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101510 · Cited by 396

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi

Chowdhary, A., Meis, J. F. G. M., Guarro, J., de Hoog, S., Kathuria, S., Arendrup, M. C., Arıkan-Akdağlı, S., Akova, M., Boekhout, T., Caira, M., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12515 · Cited by 381

Invasive candidiasis

Lass‐Flörl, C., Kanj, S. S., Govender, N. P., Thompson, G. R., Ostrosky-Zeichner, L. L., & Govrins, M. A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00503-3 · Cited by 345

Candida Species Biofilms’ Antifungal Resistance

Silva, S. M., Rodrigues, C. F., Araújo, D., Rodrigues, M. E., & Henriques, M. (2017) · Journal of Fungi · doi:10.3390/jof3010008 · Cited by 317

Echinocandin resistance: an emerging clinical problem?

Arendrup, M. C., & Perlin, D. S. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000111 · Cited by 299

How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)

Arendrup, M. C., Friberg, N., Ma, M., Kahlmeter, G., Meletiadis, J., Guinea, J., Arendrup, M., Meletiadis, J., Guinea, J., Friberg, N., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.06.007 · Cited by 248

ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients

Maschmeyer, G., Helweg‐Larsen, J., Pagano, L., Robin, C., Cordonnier, C., & Schellongowski, P. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw158 · Cited by 231

Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia

Schmiedel, Y., & Zimmerli, S. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14281 · Cited by 232

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme

Arendrup, M. C., Dzajic, E., Jensen, R. H., Johansen, H. K., Kjaldgaard, P., Knudsen, J. D., Kristensen, L., Leitz, C., Lemming, L. E., Nielsen, L., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12212 · Cited by 206

Invasive candidiasis: current clinical challenges and unmet needs in adult populations

Soriano, À., Honoré, P. M., Puerta‐Alcalde, P., García‐Vidal, C., Pagotto, A., Gonçalves, D. C., & Verweij, P. E. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad139 · Cited by 215

A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts

Bassetti, M., Marchetti, M., Chakrabarti, A., Colizza, S., Garnacho‐Montero, J., Kett, D. H., Muñóz, P., Cristini, F., Andoniadou, A., Viale, P., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-3109-3 · Cited by 198

Clinical hepatotoxicity associated with antifungal agents

Kyriakidis, I., Tragiannidis, A., Munchen, S., & Groll, A. H. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1270264 · Cited by 191

Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO)

Kochanek, M., Schalk, E., von Bergwelt‐Baildon, M., Beutel, G., Buchheidt, D., Hentrich, M., Henze, L., Kiehl, M. G., Liebregts, T., von Lilienfeld‐Toal, M., et al. (2019) · Annals of Hematology · doi:10.1007/s00277-019-03622-0 · Cited by 193

SUSCEPTIBILITY TEST FOR FUNGI: CLINICAL AND LABORATORIAL CORRELATIONS IN MEDICAL MYCOLOGY

Alastruey‐Izquierdo, A., Melhem, M. D. S. C., Bonfietti, L. X., & Rodriguez-Tudela, J. L. (2015) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652015000700011 · Cited by 184

Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer

Colombo, A. L., de Almeida, J. N., Slavin, M. A., Chen, S. C. ‐., & Sorrell, T. C. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30304-3 · Cited by 180

Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis

Jin, H., Wang, T., Falcione, B. A., Olsen, K. M., Chen, K., Tang, H., Hui, J., & Zhai, S. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw045 · Cited by 173

Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Heinz, W., Buchheidt, D., Christopeit, M., von Lilienfeld‐Toal, M., Cornely, O. A., Einsele, H., Karthaus, M., Link, H., Mahlberg, R., Neumann, S., et al. (2017) · Annals of Hematology · doi:10.1007/s00277-017-3098-3 · Cited by 170

Invasive Fungal Infection

von Lilienfeld‐Toal, M., Wagener, J., Einsele, H., Cornely, O. A., & Kurzai, O. (2019) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2019.0271 · Cited by 175

Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis

Pfaller, M. A., & Castanheira, M. (2015) · Medical Mycology · doi:10.1093/mmy/myv076 · Cited by 166

Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors—Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)

Rieger, C. T., Liss, B., Mellinghoff, S. C., Buchheidt, D., Cornely, O. A., Egerer, G., Heinz, W., Hentrich, M., Maschmeyer, G., Mayer, K. T., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy117 · Cited by 155

Emergence of azole-resistantCandida parapsilosiscausing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa

Govender, N. P., Patel, J., Magobo, R. E., Naicker, S. D., Wadula, J., Whitelaw, A. C., Coovadia, Y. M., Kularatne, R. S., Govind, C., Lockhart, S. R., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw091 · Cited by 150

Epidemiology and Outcome of Fungemia in a Cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031)

Cornely, O. A., Gachot, B., Akan, H., Bassetti, M., Uzun, Ö., Kibbler, C. C., Marchetti, O., de Burghgraeve, P., Ramadan, S., Pylkkänen, L., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ293 · Cited by 142

Critical care of patients with cancer

Shimabukuro‐Vornhagen, A., Böll, B., Kochanek, M., Azoulay, E., & von Bergwelt‐Baildon, M. S. (2016) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21351 · Cited by 136

Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.

Arendrup, M. C., Cuenca-Estrella, M., Lass-Flörl, C., & Hope, W. W. (2013) · Drug Resistance Updates · doi:10.1016/j.drup.2014.01.001 · Cited by 129

Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern

Astvad, K. M. T., Johansen, H. K., Røder, B. L., Rosenvinge, F. S., Knudsen, J. D., Lemming, L., Schønheyder, H. C., Hare, R. K., Kristensen, L., Nielsen, L., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01564-17 · Cited by 125

Current status of antifungal resistance and its impact on clinical practice

Alcázar‐Fuoli, L., & Mellado, E. (2014) · British Journal of Haematology · doi:10.1111/bjh.12896 · Cited by 118

Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)

Cesaro, S., Ljungman, P. T., Mikulska, M., Hirsch, H. H., von Lilienfeld‐Toal, M., Cordonnier, C., Meylan, S., Mehra, V., Styczyński, J., Marchesi, F., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01578-1 · Cited by 120

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases

Cornely, O. A., Cuenca‐Estrella, M., Meis, J. F. G. M., & Ullmann, A. J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12569 · Cited by 118

Safety and Pharmacokinetics of Isavuconazole as Antifungal Prophylaxis in Acute Myeloid Leukemia Patients with Neutropenia: Results of a Phase 2, Dose Escalation Study

Cornely, O. A., Böhme, A., Schmitt‐Hoffmann, A. H., & Ullmann, A. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04569-14 · Cited by 115

Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry

Aslani, N., Janbabaei, G., Abastabar, M., Meis, J. F., Babaeian, M., Khodavaisy, S., Boekhout, T., & Badali, H. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-017-2916-5 · Cited by 114

Treatment of Invasive Candidiasis: A Narrative Review

Ben-Ami, R. (2018) · Journal of Fungi · doi:10.3390/jof4030097 · Cited by 111

Epidemiology of Invasive Candidiasis

Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology · doi:10.2147/clep.s459600 · Cited by 109

Epidemiology, Management, and Outcome of Invasive Fungal Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation in China: A Multicenter Prospective Observational Study

Sun, Y., Meng, F., Han, M., Zhang, X., Yu, L., Huang, H., Wu, D., Ren, H., Wang, C., Shen, Z., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.03.018 · Cited by 107

Prevention of Infections During Primary Immunodeficiency

Aguilar, C., Malphettes, M., Donadieu, J., Chandesris, M., Coignard-Biehler, H., Catherinot, É., Pellier, I., Stephan, J., Moing, V. L., Barlogis, V., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu646 · Cited by 105

Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, againstCandidaandAspergillusspp., including echinocandin- and azole-resistant isolates

Pfaller, M. A., Messer, S. A., Rhomberg, P. R., Jones, R. N., & Castanheira, M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw214 · Cited by 103

Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure

Lewis, J. S., Wiederhold, N. P., Wickes, B. L., Patterson, T. F., & Jorgensen, J. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01144-13 · Cited by 101

FEBRILE NEUTROPENIA IN ACUTE LEUKEMIA. EPIDEMIOLOGY, ETIOLOGY, PATHOPHYSIOLOGY AND TREATMENT

Hansen, B., Wendelbo, Ø., Bruserud, Ø., Hemsing, A. L., Mosevoll, K. A., & Reikvam, H. (2019) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2020.009 · Cited by 103

Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)

Penack, O., Becker, C., Buchheidt, D., Christopeit, M., Kiehl, M. G., von Lilienfeld‐Toal, M., Hentrich, M., Reinwald, M., Salwender, H. J., Schalk, E., et al. (2014) · Annals of Hematology · doi:10.1007/s00277-014-2086-0 · Cited by 102

Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology ( AGIHO )

Ruhnke, M., Behre, G., Buchheidt, D., Christopeit, M., Hamprecht, A. G., Heinz, W., Heußel, C. P., Horger, M., Kurzai, O., Karthaus, M., et al. (2018) · Mycoses · doi:10.1111/myc.12838 · Cited by 100

Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies

Ljungman, P. T., Alain, S., Chemaly, R. F., Einsele, H., Galaverna, F., Hirsch, H. H., Sadowska‐Klasa, A., Navarro, D., Styczyński, J., & de la Cámara, R. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(25)00069-6 · Cited by 99

Candidemia: Evolution of Drug Resistance and Novel Therapeutic Approaches

Tortorano, A. M., Prigitano, A., Morroni, G., Brescini, L., & Barchiesi, F. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s274872 · Cited by 104

Consensus statement for cancer patients requiring intensive care support

Kiehl, M. G., Beutel, G., Böll, B., Buchheidt, D., Forkert, R., Fuhrmann, V., Knöbl, P., Kochanek, M., Kroschinsky, F., Rosée, P. G. L., et al. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3312-y · Cited by 95

Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Christopeit, M., Schmidt‐Hieber, M., Sprute, R., Buchheidt, D., Hentrich, M., Karthaus, M., Penack, O., Ruhnke, M., Weißinger, F., Cornely, O. A., et al. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04297-8 · Cited by 93

Differential activity of the oral glucan synthase inhibitor SCY-078 against wild-type and echinocandin-resistant strains of Candida species

Pfaller, M. A., Messer, S. A., Rhomberg, P. R., Borroto-Esoda, K., & Castanheira, M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00161-17 · Cited by 84

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin

Wasmann, R. E., Muilwijk, E. W., Burger, D. M., Verweij, P. E., Knibbe, C. A. J., & Brüggemann, R. J. M. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0578-5 · Cited by 86

Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain

Puig‐Asensio, M., Ruíz-Camps, I., Fernández‐Ruiz, M., Aguado, J. M., Muñóz, P., Valerio, M., Delgado‐Iribarren, A., Merino, P., Bereciartúa, E., Fortün, J., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.12.027 · Cited by 79

Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7‐year study

Tadec, L., Talarmin, J., Gastinne, T., Bretonnière, C., Miegeville, M., Pape, P. L., & Morio, F. (2016) · Mycoses · doi:10.1111/myc.12470 · Cited by 79

Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China

Sun, Y., Huang, H., Chen, J., Li, J., Ma, J., Li, J., Liang, Y., Wang, J., Li, Y., Kang, Y., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-2649-7 · Cited by 78

Treatment of invasive fungal diseases in cancer patients—Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Ruhnke, M., Cornely, O. A., Schmidt‐Hieber, M., Alakel, N., Boell, B., Buchheidt, D., Christopeit, M., Hasenkamp, J., Heinz, W., Hentrich, M., et al. (2020) · Mycoses · doi:10.1111/myc.13082 · Cited by 76

Improving outcome of fungal diseases – Guiding experts and patients towards excellence

Cornely, O. A., Lass‐Flörl, C., Lagrou, K., Arsić-Arsenijević, V. S., & Hoenigl, M. (2017) · Mycoses · doi:10.1111/myc.12628 · Cited by 75

Use of Micafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 3,764 Clinical Isolates of Candida by Use of CLSI Methods and Interpretive Criteria

Pfaller, M. A., Messer, S. A., Diekema, D. J., Jones, R. N., & Castanheira, M. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02481-13 · Cited by 74

Antifungal Susceptibility Profiles of Bloodstream Yeast Isolates by Sensititre YeastOne over Nine Years at a Large Italian Teaching Hospital

Posteraro, B., Spanu, T., Fiori, B., Maio, F. D., Carolis, E. D., Giaquinto, A., Prete, V., Angelis, G. D., Torelli, R., D’Inzeo, T., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00285-15 · Cited by 74

Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus

Henze, L., Buhl, C., Sandherr, M., Cornely, O. A., Heinz, W., Khodamoradi, Y., Kiderlen, T. R., Koehler, P. A., Seidler, A., Sprute, R., et al. (2022) · Annals of Hematology · doi:10.1007/s00277-021-04746-y · Cited by 79

Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL)

Pagano, L., Maschmeyer, G., Lamoth, F., Blennow, O., Xhaard, A., Spadea, M., Busca, A., Cordonnier, C., Maertens, J. A., On behalf of, E. C. I. L., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02586-7 · Cited by 71

Epidemiology, species distribution and outcome of nosocomial Candida spp.bloodstream infection in Shanghai

Yang, Z., Wu, L., Liu, X., Zhou, M., Li, J., Wu, J., Cai, Y., Mao, E., Chen, E., & Lortholary, O. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-241 · Cited by 70

Rapid Development of Candida krusei Echinocandin Resistance during Caspofungin Therapy

Forastiero, A., Garcia-Gil, V., Rivero-Menéndez, O., Garcia‐Rubio, R., Monteiro, M. C., Alastruey‐Izquierdo, A., Jordán, R., Agorio, I., & Mellado, E. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01005-15 · Cited by 70

Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections

Lamoth, F., Lewis, R. E., & Kontoyiannis, D. P. (2020) · Journal of Fungi · doi:10.3390/jof7010017 · Cited by 68

Positions and Numbers of FKS Mutations in Candida albicans Selectively Influence In Vitro and In Vivo Susceptibilities to Echinocandin Treatment

Lackner, M., Tscherner, M., Schaller, M., Kuchler, K., Mair, C., Sartori, B., Istel, F., Arendrup, M. C., & Lass-Flörl, C. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00123-14 · Cited by 67

Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes

Song, J., & Stevens, D. A. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2015.1068271 · Cited by 62

Systemic Antifungal Agents: Current Status and Projected Future Developments

Seyedmousavi, S., Rafati, H., İlkit, M., Tolooe, A., Hedayati, M. T., & Verweij, P. E. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6515-1_5 · Cited by 62

Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis

Schwarz, C., Hartl, D., Eickmeier, O., Hector, A., Benden, C., Durieu, I., Solé, A., Gärtner, S., Milla, C. E., & Barry, P. J. (2017) · Mycopathologia · doi:10.1007/s11046-017-0182-0 · Cited by 61

Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis

Tonin, F. S., Steimbach, L. M., Borba, H. H. L., Sanches, A. C. C., Wiens, A., Pontarolo, R., & Fernández-Llimós, F. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12802 · Cited by 61

Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002–14)

Bretagne, S., Renaudat, C., Desnos‐Ollivier, M., Sitbon, K., Lortholary, O., Dromer, F., & on behalf of the French Mycosis Study Group (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx045 · Cited by 62

What are the 100 most cited fungal genera?

Bhunjun, C. S., Chen, Y. J., Phukhamsakda, C., Boekhout, T., Groenewald, J. Z., McKenzi, E. H. C., Francisco, E. C., Frisvad, J. C., Groenewald, M., Hurdeal, V. G., et al. (2024) · Studies in Mycology · doi:10.3114/sim.2024.108.01 · Cited by 58

Susceptibility testing of fungi to antifungal drugs

Sanguinetti, M., & Posteraro, B. (2018) · Journal of Fungi · doi:10.3390/jof4030110 · Cited by 55

Use of Anidulafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 4,290 Clinical Isolates of Candida by Using CLSI Methods and Interpretive Criteria

Pfaller, M. A., Diekema, D. J., Jones, R. N., & Castanheira, M. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00782-14 · Cited by 51

Multicenter Study of Anidulafungin and Micafungin MIC Distributions and Epidemiological Cutoff Values for Eight Candida Species and the CLSI M27-A3 Broth Microdilution Method

Pfaller, M. A., Espinel‐Ingroff, A., Bustamante, B., Cantón, R., Diekema, D. J., Fothergill, A., Fuller, J., González, G. M., Guarro, J., Lass‐Flörl, C., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02020-13 · Cited by 51

Breakthrough candidaemia in the era of broad-spectrum antifungal therapies

Cuervo, G., Garcia-Vidal, C., Nucci, M., Puchades, F., Fernández-Ruiz, M., Obed, M., Manzur, A., Gudiol, C., Pemán, J., Aguado, J. M., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.09.029 · Cited by 49

New developments and directions in the clinical application of the echinocandins

Chang, C. C., Slavin, M. A., & Chen, S. C. A. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1916-3 · Cited by 51

2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy

Giesen, N., Sprute, R., Rüthrich, M. M., Khodamoradi, Y., Mellinghoff, S. C., Beutel, G., Lueck, C., Koldehoff, M., Hentrich, M., Sandherr, M., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.01.033 · Cited by 48

Effects of antifungal stewardship using therapeutic drug monitoring in voriconazole therapy on the prevention and control of hepatotoxicity and visual symptoms: A multicentre study conducted in Japan

Hamada, Y., Ueda, T., Miyazaki, Y., Nakajima, K., Fukunaga, K., Miyazaki, T., Nakada, N., Nagao, M., Kawamura, H., Shigemi, A., et al. (2020) · Mycoses · doi:10.1111/myc.13129 · Cited by 47

Up to date epidemiology, diagnosis and management of invasive fungal infections

Oren, I., & Paul, M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12642 · Cited by 46

Isavuconazole and Nine Comparator Antifungal Susceptibility Profiles for Common and Uncommon Candida Species Collected in 2012: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values

Castanheira, M., Messer, S. A., Rhomberg, P. R., Dietrich, R. D., Jones, R. N., & Pfaller, M. A. (2014) · Mycopathologia · doi:10.1007/s11046-014-9772-2 · Cited by 46

Old and new pathogenicNakaseomycesspecies: epidemiology, biology, identification, pathogenicity and antifungal resistance

Angoulvant, A., Guitard, J., & Hennequin, C. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov114 · Cited by 45

Outbreaks of Fungal Infections in Hospitals: Epidemiology, Detection, and Management

Douglas, A. P., Stewart, A. G., Halliday, C. L., & Chen, S. C. ‐. (2023) · Journal of Fungi · doi:10.3390/jof9111059 · Cited by 50

EUCAST Technical Note on Candida and micafungin, anidulafungin and fluconazole

Cavling Arendrup, M., Cuenca‐Estrella, M., Lass‐Flörl, C., Hope, W. W., & The European Committee on Antimicrobial Susceptibility Testing – Subcommittee on Antifungal Susceptibility Testing (EUCAST‐AFST) (2014) · Mycoses · doi:10.1111/myc.12170 · Cited by 43

Impact of special patient populations on the pharmacokinetics of echinocandins

Muilwijk, E. W., Lempers, V. J. C., Burger, D. M., Warris, A., Pickkers, P., Aarnoutse, R. E., & Brüggemann, R. J. M. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1028366 · Cited by 43

Emerging Candida species isolated from renal transplant recipients: Species distribution and susceptibility profiles

Diba, K., Makhdoomi, K., Nasri, E., Vaezi, A., Javidnia, J., Gharabag, D. J., Jazani, N. H., Chavshin, A. R., Badiee, P., Badali, H., et al. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.09.026 · Cited by 43

Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal

Leroux, S., & Ullmann, A. J. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12426 · Cited by 42

Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus

Mirabile, A., Numico, G., Russi, E. G., Bossi, P., Crippa, F., Bacigalupo, A., Sanctis, V. D., Musso, S., Merlotti, A. M., Ghi, M. G., et al. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.03.003 · Cited by 42

Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects

Akan, H., Antia, V., Kouba, M., Sinkó, J., Tanase, A. D., Vrḫovac, R., & Herbrecht, R. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt389 · Cited by 42

Performance of two MALDI-TOF MS systems for the identification of yeasts isolated from bloodstream infections and cerebrospinal fluids using a time-saving direct transfer protocol

Hamprecht, A. G., Christ, S., Oestreicher, T., Plum, G., Kempf, V. A. J., & Göttig, S. (2013) · Medical Microbiology and Immunology · doi:10.1007/s00430-013-0319-9 · Cited by 41

Echinocandin Resistance in Candida Species: a Review of Recent Developments

Wiederhold, N. P. (2016) · Current Infectious Disease Reports · doi:10.1007/s11908-016-0549-2 · Cited by 41

Emergence of resistantCandida glabratain Germany

Aldejohann, A. M., Herz, M., Martin, R., Walther, G., & Kurzai, O. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab122 · Cited by 43

Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Transplantation

Cesaro, S., Tridello, G., Blijlevens, N. M. A., Ljungman, P. T., Craddock, C., Michallet, M., Martin, A. M., Snowden, J. A., Mohty, M., Maertens, J. A., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy150 · Cited by 40

Hepatosplenic candidiasis

Cornely, O. A., Bangard, C., & Jaspers, N. (2015) · Clinical Liver Disease · doi:10.1002/cld.491 · Cited by 39

Micafungin

Scott, L. J. (2012) · Drugs · doi:10.2165/11209970-000000000-00000 · Cited by 39

Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

Giesen, N., Sprute, R., Rüthrich, M. M., Khodamoradi, Y., Mellinghoff, S. C., Beutel, G., Lueck, C., Koldehoff, M., Hentrich, M., Sandherr, M., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.09.009 · Cited by 38

Micafungin breakthrough fungemia in patients with hematological disorders

Kimura, M., Araoka, H., Yamamoto, H., Nakamura, S., Nagi, M., Yamagoe, S., Miyazaki, Y., Ogura, S., Mitsuki, T., Yuasa, M., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02183-17 · Cited by 37

P971 Amphotericin B does not affect the pharmacokinetics of micafungin (FK463)

Undre, N. A., Stevenson, P., & Wilbraham, D. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(07)70812-9

Management of invasive mycoses in hematology patients: current approaches.

Perfect, J. R. (2004) · PubMed · Cited by 13

Candidaemia in Patients with Haematological Disorders and Stem Cell Transplant

Al‐Anazi, K. A., & Al-Jasser, A. M. (2006) · Libyan Journal of Medicine · doi:10.3402/ljm.v1i2.4673 · Cited by 5

Candidemia in Cancer Patients: Focus Mainly on Hematological Malignancyand Hematopoietic Stem Cell Transplantation

Okinaka, K. (2016) · Medical Mycology Journal · doi:10.3314/mmj.16.003 · Cited by 4

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

Tissot, F., Agrawal, S., Pagano, L., Petrikkos, G., Groll, A. H., Skiada, A., Lass-Flörl, C., Calandra, T., Viscoli, C., & Herbrecht, R. (2017) · Haematologica · doi:10.3324/haematol.2016.152900 · Cited by 682